The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine Sequential Therapy
Clinical trial NCT06388720 · RECRUITING
Trial details
- NCT number
- NCT06388720
- Sponsor
- National Cancer Center, Korea
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-19
- Primary completion
- 2027-12-31
- Enrollment
- 82
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.